Advertisement

Topics

GBF - Gesellschaft für Biotechnologische Forschung mbH Company Profile

01:12 EST 17th December 2018 | BioPortfolio

The GBF is an infection research center of the Helmholtz Association, the largest scientific organisation in Germany. Our primary focus is on pathogens which are either medically relevant or which can be used as models for researching the mechanisms of infection. The GBF is funded by the Federal Republic of Germany and the state of Lower Saxony (90:10). The GBF employs some 600 people and has an annual budget of approximately €47 million.

Location

Mascheroder Weg 1
Braunschweig
D-38124
Germany

Contact

Phone: 49 ( 0 ) 531.6181-0
Fax: 49 (0) 531.6181-515
Email: info@gbf.de


News Articles [98 Associated News Articles listed on BioPortfolio]

Novartis beendet Forschung zu Infektionskrankheiten

Zürich (awp) - Der Pharmakonzern Novartis verabschiedet sich aus der Forschung bei Infektionskrankheiten. Dem Rückzug sollen laut einem Bericht der Nachrichtenagentur Bloomberg 140 Stellen an der a....

Förderung für "Neue biotechnologische Prozesse auf der Grundlage mariner Ressourcen – BioProMare"

WIEDERERWECKT: VIPs leisten Stanley Tucci Gesellschaft bei einem exklusiven ...

LONDON, October 26, 2018 /PRNewswire/ -- Gestern leisteten VIP-Gäste dem renommierten Schauspieler, Schriftsteller, Regisseur und Produzenten Stanley Tucci Gesellschaft, als Johnnie Walker die Enthü...

Neueste Stevia-Forschung im Journal of Nutrition veröffentlicht

CHICAGO, 25. Juli 2018 /PRNewswire/ -- The Journal of Nutrition veröffentlichte in seiner Ausgabe vom Juli 2018 eine ausführliche Übersichtsarbeit über die neueste wissenschaftliche Stevia-Forschu...

Affymetrix Genechip Fluidics Station 400/450 Genetik Forschung Flüssig

EUR 408,47Angebotsende: Freitag Dez-28-2018 16:06:23 CETSofort-Kaufen für nur: EUR 408,47Sofort-Kaufen | Zur Liste der beobachteten Artikel hinzufügen Biotech365 : Affymetrix Genechip Fluidics ...

Affymetrix Genechip Fluidics Station 450 Flüssig Handhabung Genetic Forschung

EUR 361,37Angebotsende: Montag Dez-31-2018 16:21:51 CETSofort-Kaufen für nur: EUR 361,37Sofort-Kaufen | Zur Liste der beobachteten Artikel hinzufügen Biotech365 : Affymetrix Genechip Fluidics S...

KIT erklimmt nächste Stufe: Bund und Land treiben Weiterentwicklung entschlossen voran

Um das Karlsruher Institut für Technologie (KIT) in seiner wissenschaftlichen Leistungsfähigkeit weiter zu unterstützen und konsequent fortzuentwickeln, wollen Bund und Land die mutige Fusion von 2...

Innovative Projekte im Bereich der angewandten Forschung – "Deutsch-Ägyptischer Forschungsfond" (GERF)

Drugs and Medications [0 Results]

None

Clinical Trials [6 Associated Clinical Trials listed on BioPortfolio]

A Study of the Current Medical Practice and Outcomes in the Treatment of Type 2 Diabetes Mellitus in an Office Setting (MK-0431-199)

The purpose of this study is to collect information of the risk profile of patients with type 2 diabetes mellitus, their treatment concerning meeting the guidelines for treatment of diabet...

Ultrasound Evaluation of the IVC in Addition to Clinical Assessment to Guide Decongestion in ADHF

CAVA-ADHF is designed as a prospective, randomized, controlled, patient-blinded, multicenter, parallel-group trial. The objective is to test whether evaluation of the inferior vena cava di...

Opsoclonus Myoclonus Syndrome/Dancing Eye Syndrome (OMS/DES) in Children With and Without Neuroblastoma (NBpos and NBneg)Opsoclonus Myoclonus Syndrome/Dancing Eye Syndrome (OMS/DES) in Children With and Without Neuroblastoma (NBpos and NBneg)

The OMS/DES study is a multinational European Trial for Children with the Opsoclonus Myoclonus Syndrome / Dancing Eye Syndrome. This trial brought on the way by specialists of the EPNS (E...

Ziprasidone for Severe Conduct and Other Disruptive Behavior Disorders

To investigate and compare the efficacy, safety and tolerability of ziprasidone versus placebo in the treatment of conduct disorder (CD), oppositional defiant disorder (ODD) and disruptive...

Effects of Empagliflozin Plus Linagliptin vs Metformin Plus Insulin Glargin on Renal and Vascular Changes in Type 2 Diabetes

Diabetes mellitus is a wide-spread disease accompanied by strongly increased morbidity and mortality due to micro- and macrovascular complications. However, in studies with patients suffer...

Companies [28 Associated Companies listed on BioPortfolio]

GBF - Gesellschaft für Biotechnologische Forschung mbH

The GBF is an infection research center of the Helmholtz Association, the largest scientific organisation in Germany. Our primary focus is on pathogens which are either medically relevant or which can...

ICHTHYOL-GESELLSCHAFT

ICHTHYOL-GESELLSCHAFT, our independent, family-run pharmaceutical company became one of the most important suppliers of therapeutics in dermatology and orthopedics due to active ingredients of high gr...

Forschung & Lehre

NIL

Gesellschaft für Toxikologie (GT)

NIL

Gesellschaft Deutscher Chemiker

Nil

More Information about "GBF - Gesellschaft für Biotechnologische Forschung mbH" on BioPortfolio

We have published hundreds of GBF - Gesellschaft für Biotechnologische Forschung mbH news stories on BioPortfolio along with dozens of GBF - Gesellschaft für Biotechnologische Forschung mbH Clinical Trials and PubMed Articles about GBF - Gesellschaft für Biotechnologische Forschung mbH for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of GBF - Gesellschaft für Biotechnologische Forschung mbH Companies in our database. You can also find out about relevant GBF - Gesellschaft für Biotechnologische Forschung mbH Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Infectious-diseases
Antiretroviral Therapy Clostridium Difficile Ebola HIV & AIDS Infectious Diseases Influenza Malaria Measles Sepsis Swine Flu Tropical Medicine Tuberculosis Infectious diseases are caused by pathogenic...


Corporate Database Quicklinks



Searches Linking to this Company Record